Exigency for fusion of graphene and carbon nanotube with biomaterials

Biomaterial industry is a widely growing field that is closely related to advanced materials. With development in fabrication techniques new materials are being created by researchers daily. The currently used biomaterials for biomedical applications have some limitations. This review examines those limitations such as corrosion, short fatigue life, less wear resistance, and inadequate mechanical properties. These limitations may lead to adverse effects. To overcome these limitations carbon-based nanomaterials may be incorporated such that these biomaterials reach the level of ideal biomaterials. Upgrade of biomaterials with graphene and carbon nanotubes (CNTs) needs to be done only after checking the safety profile of these materials. Biocompatibility of functionalized graphene and CNT is found to be adequate for the use in many applications such as drug delivery, biosensing and imaging, cancer therapeutics, and tissue regeneration whereas pristine graphene and CNT may produce adverse effects. The potential of carbon-based nanomaterials and graphene (and its derivatives) in overcoming those limitations and enhancing biological activities of ongoing biomaterials by acting as composites and coating material is examined. In addition, nanomaterials employ new techniques in biomedical application such as cancer therapy for more efficient results.     

Anticipated pharmacological role of Aviptadil on COVID-19

Environmental Science and Pollution Research - Vasoactive intestinal peptide (VIP) is a neuropeptide that is produced by the lymphoid cells and plays a major role in immunological functions for...